Advertisement

Tumors and Aging: The Influence of Age-Associated Immune Changes Upon Tumor Growth and Spread

  • William B. Ershler
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 330)

Abstract

There has been a clinical impression that tumors are less malignant in older people. Such has been claimed for breast, colon, prostate and lung carcinomas (Schottenfield and Robbins, 1971; Berkson et al., 1957, Calabrese et al., 1973; Ershler et al., 1983; Pickren et al., 1982; Suen et al., 1974). The great heterogeneity in clinical populations, confounded by antecedent illness, medicines, exposures, and social circumstances have precluded a statistical confirmation of such age-associated changes. Nonetheless, in experimental animals, ’we and others have found significant differences in tumor growth and spread when the common variable is host age. Weakly immunogenic tumors such as B16 melanoma or Lewis lung carcinoma (3LL) growrnore slowly in old mice, but more immunogenic tumors such as methylcholanthrene-induced fibrosarcomas grow more rapidly. We have explored a variety of proposed mechanisms for the observed differences and have concluded that the age-associated decline in immune function (immune senescence) is central to the reduced aggressiveness of weakly antigenic tumors in older hosts.

Keywords

Spleen Cell Lewis Lung Carcinoma Slow Tumor Growth Immune Competence Immunogenic Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anisimov, V.N. Carcinogenesis and aging. Adv. in Cancer Research 40:365 (1983).CrossRefGoogle Scholar
  2. Antonaci, S., Jirillo, E., Ventura, M.T., Garofolo, A.R., and Bonomo, L. Nonspecific immunity in aging: Deficiency of monocyte and polymorphonuclear cell mediated functions. Mechanisms of Ageing and Development 24:367 (1984).PubMedCrossRefGoogle Scholar
  3. Auerbach, R.A., Kubai, L. and Sidky, Y. Angiogenesis induction by tumors, embryonic tissue and lymphocytes. Cancer Research 36:3435 (1976).PubMedGoogle Scholar
  4. Baniyash, M., Smorodinsky, N.I., Yaakubovicz, M., Witz, LP. Serologically detectable MHC and tumor associated antigens on B16 melanoma variants and humoral immunity in mice bearing these tumors. J. Immunol. 129:1318 (1982).PubMedGoogle Scholar
  5. Berendt, M.J. and North, R.J. T-cell mediated suppression of anti-tumor immunity. An explanation for the progressive growth of an immunogenic tumor. J. Exp. Med. 151:69 (1980).PubMedCrossRefGoogle Scholar
  6. Berkson, J., Harrington, S.W., Clagett, O.T., Kirklin, J.W., Dockerty, M.B. and McDonald, J.R. Mortality and survival in surgically treated cancer of the breast: A statistical summary of some experience of the Mayo Clinic. Mayo Clin. Proc. 32:645 (1957).Google Scholar
  7. Bradley, S.F., Vibhagool, A., Kunkel, S.L., and Kauffman, C.A. Monokine secretion in aging and protein malnutrition. J. Leukocyte Biology. 45:510 (1989).Google Scholar
  8. Broder, S. and Waldmann, T.A. The suppressor-cell network in cancer. New Eng. J. Med. 299:1281, 13351 (1978).Google Scholar
  9. Bruley-Rosset, M. and Vergnon, I. Interleukin-1 synthesis and activity in aged mice. Mechanisms of Ageing and Development 24:247 (1984).PubMedCrossRefGoogle Scholar
  10. Bystryn, J.C. Release of tumor associated antigens by murine melanoma cells. J. Immunol. 116:1302 (1976).PubMedGoogle Scholar
  11. Calabrese, C.T., Adam, Y.G., Volk, H. Geriatric colon cancer. Am. J. Surgery 125:181 (1973).CrossRefGoogle Scholar
  12. Callard, R.E. and Basten, A. Immune function in aged mice. II. B-cell function. Cellular Immunol. 31:26 (1977).CrossRefGoogle Scholar
  13. Celik, C., Lewis, D.A. and Goldrosen, M.H. Demonstration of immunogenicity with the poorly immunogenic B16 melanoma. Cancer Research 43:3507 (1983).PubMedGoogle Scholar
  14. Chang, M.P., Makinodan, T., Peterson, W.J. and, Strehler, B.L. Role of T-cells and adherent cells in age-related decline in murine interleukin-2 production. J. Immunol. 129:2426 (1983).Google Scholar
  15. Eijan, A.M., Jasnis, M.A., Kohan, S.S., and Oisgold-Daga, S. Nature of the spleen cell populations capable of releasing tumor-enhancing factors. J. Surg. Oncol. 36:161 (1987).PubMedCrossRefGoogle Scholar
  16. Eijan, A.M., Jasnis, M.A., Motta, B., and Oisgold-Daga, S. Isolated soluble fractions from spleen cell culture supernatants induce tumor-enhancement. J. Surg. Oncol. 41:134 (1989).PubMedCrossRefGoogle Scholar
  17. Ershler, W.B., Gamelli, R.L., Moore, A.L., Hacker, M.P., and Blow, A.J. Experimental tumors and aging: Local factors that may account for the observed age advantage in the B16 murine melanoma model. Exp. Gerontol. 19:367 (1984a).PubMedCrossRefGoogle Scholar
  18. Ershler, W.B., Moore, A.L., Roessner, K., and Ranges, G.E. Interleukin-2 and aging: Decreased IL-2 production in healthy older people does not correlate with reduced helper cell numbers or antibody response to influenza vaccine and is not corrected in vitro by Thymosin Alpha One. Immunopharmacol. 10:11 (1986).CrossRefGoogle Scholar
  19. Ershler, W.B., Moore, A.L., Shore, H., and Gamelli, R.L. Transfer of age-associated restrained tumor growth in mice by old to young bone marrow transplantation. Cancer Research 44:5677 (1984b).PubMedGoogle Scholar
  20. Ershler, W.B., Socinski, M.A., and Greene, C.J. Bronchogenic cancer, metastases and aging. J. Am. Ger. Soc. 31:673 (1983).Google Scholar
  21. Ershler, W.B., Stewart, J.A., Hacker, M.P., Moore, A.L. and Tindle, B.H. B16 murine melanoma and aging: Slower growth and longer survival in old mice. J. Nat. Can. Inst. 72:161 (1984c).Google Scholar
  22. Ershler, W.B., Tuck, D., Moore, A.L., Klopp, R.G., and Kaesberg, P.R. Immunologic enhancement of growth of B16 melanoma. Cancer 61:1792 (1988).PubMedCrossRefGoogle Scholar
  23. Fidler, I.J., Gersten, D.M. and Riggs, C.W. Relationship of host immune status to tumor cell arrest, distribution and survival in experimental metastases. Cancer 40:46 (1977).PubMedCrossRefGoogle Scholar
  24. Fidler, I.J. and Nicholson, G.L. Tumor cells and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma. Israel J. Med. Sci. 14:38(1978).PubMedGoogle Scholar
  25. Fidler, I.J. Immune stimulation-inhibition of experimental cancer metastases. Cancer Research. 34:481(1974).Google Scholar
  26. Fisher, M.S. and Kripke, M.L. Further studies on the tumor-specific suppressor cells induced by ultraviolet radiation. J. Immunol. 121:1139 (1978).PubMedGoogle Scholar
  27. Fisher, M.S. and Kripke, M.L. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Proc. Nat. Acad. Sci. (USA). 74:1688 (1977).CrossRefGoogle Scholar
  28. Flood, P.M., Urban, J.L, and Kripke, M.L, and Schreiber, H. Loss of tumorspecific and idiotype-specific immunity with age. J. Exp. Med. 154:275 (1980).CrossRefGoogle Scholar
  29. Fong, T.C., and Makinodan, T. In situ hybridization analysis of the age-associated decline in IL-2 messenger RNA expressing murine T-cells. Cellular Immunology 118:199 (1989).PubMedCrossRefGoogle Scholar
  30. Fujimoto, S., Greene, M.I., and Sehon, A.H. Regulation of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. J. Immunol. 116:791 (1976a).PubMedGoogle Scholar
  31. Fujimoto, S., Greene, M.I., Sehon, A.H. Regulation of the immune response to tumor antigens. II. The nature of the immunosuppressor cells in tumor-bearing hosts. J. Immunol. 116:800 (1976b).PubMedGoogle Scholar
  32. Gillis, S., Kozak, R., Durante, M., and Weksler, M.E. Immunologie studies of aging: Decreased production and response to T-cell growth factor by lymphocytes from aged humans. J. Clin. Invest. 67:942 (1981).CrossRefGoogle Scholar
  33. Greene, E.L. Handbook on genetically standardized JAX mice. Second ed., Bar Harbor Times Publishing Co., Bar Harbor, Maine (1977).Google Scholar
  34. Greene, M.L., Dorf, M.E., Pierres, M., and Benacerraf, B. Reduction of syngenic tumor growth by an I-J alloantiserum. Proc. Nat. Acad. Sci. (USA) 74:5118 (1977).CrossRefGoogle Scholar
  35. Hadar, E., Ershler, W.B., Kreisle, R.A., Ho, S.P., Volk, M.J., and Klopp, R.G. Lymphocyte induced angiogenesis factor is produced by L3T4+ murine T lymphocytes, and its production declines with age. Cancer Immunol Immunotherapy. 26:31 (1988).CrossRefGoogle Scholar
  36. Hamburger, A.W., Salmon, S.E., Kim, M.B., Sochlness, B., Trent, J.M., Alberts, D.S., and Schmidt, H. Direct cloning of human ovarian carcinoma cells in agar. Cancer Research 38:3438 (1978).PubMedGoogle Scholar
  37. Hamburger, A.W., White, C.P., Lurie, K., and Kaplan, R. Monocyte-derived growth factors for human tumor clonogenic cells. J. Leukocyte Biology 40:381 (1986).Google Scholar
  38. Hamburger, A.W., White, C.P. Interactions between macrophage and human clonogenic cells. Stem Cells 1:209 (1982).PubMedGoogle Scholar
  39. Hellstrom, I., Hellstrom, K.E., Evans, C.A., Heppner, G.H., Pierce, G.E., and Yang, J.P.S. Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor specific antigens. Proc. Nal. Acad. Sci. (USA). 62:362 (1969).CrossRefGoogle Scholar
  40. Hellstrom, K.E. and Hellstrom I. Immunologic enhancement of tumor growth, In: Green, I., Cohen, S., McCluskey, R.T. eds. Mechanisms of Tumor Immunity. Wiley, New York (1977).Google Scholar
  41. Inamizu, T., Chang, M.P., and Makinodan, T. Influence of age on the production and regulation of interleukin-1 in mice. Immunology 55:447 (1985).PubMedGoogle Scholar
  42. Isakov, N., Segal, S., Hollander, N. and Feldman, M. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effects on tumor growth and antibody production. Int. J. Cancer 22:465 (1978).PubMedCrossRefGoogle Scholar
  43. Kaesberg, P.R. and Ershler, W.B. The change in tumor aggressiveness with age: Lessons from experimental animals. Seminars in Oncology 16:28 (1989).PubMedGoogle Scholar
  44. Kreisle, R.A. and Ershler, W.B. Investigation of tumor angiogenesis in an intradermal mouse model: Role of host-tumor interactions. J. Nat. Cancer Inst. 80:849 (1989).CrossRefGoogle Scholar
  45. Kubota, K., Kubota, R., Takeda, S., and Matsuzawa, T. Effect of age and sex of host mice on growth and differentiation of teratocarcinomas OTT6050. Exp. Gerontol. 16:371 (1981).PubMedCrossRefGoogle Scholar
  46. Murasko, D.M. and Prehn, R.T. Ability of immune reactivity to potentiate tumor growth. In: Ray, P.K. ed., Immunobiology of Transplantation, Cancer and Pregnancy. Pergamon Press, New York (1983).Google Scholar
  47. North, R.J. The murine anti-tumor immune response and its therapeutic manipulation. Adv. Immunol. 35:89 (1984).PubMedCrossRefGoogle Scholar
  48. Pickren, J.W., Tsukada, Y., and Lane, W.W. Liver metastasis: Analysis of autopsy data. In: Weiss, H.J. and Gilbert, H.A. eds., Liver Metastases. G.K. Hall, Boston (1982).Google Scholar
  49. Prehn, R.T. and Lappe, M.A. An immunostimulation theory of tumor development. Transplant Rev. 7:26 (1971).PubMedGoogle Scholar
  50. Prehn, R.T. Perspectives in oncogenesis: Does immunity stimulate or inhibit neoplasia? Res. J. Reticuloendothelial Soc. 10:1 (1971).Google Scholar
  51. Prehn, R.T. The immune reaction as a stimulator of tumor growth. Science 176:170 (1972).PubMedCrossRefGoogle Scholar
  52. Price, G.B. and Makinodan, T. Immunologic deficiencies in senescence. I. Characterization of intrinsic deficiencies. J. Immunol. 108:403 (1972).PubMedGoogle Scholar
  53. Proctor, J.W., Rudenstam, C.M., and Alexander, P. A factor preventing the development of lung metastases in rats with sarcomas. Nature 242:29 (1973).PubMedCrossRefGoogle Scholar
  54. Rabatic, S., Sabioncello, A., Dekaris, D., and Kardum, I. Age-related changes in functions of peripheral blood phagocytes. Mechanisms of Ageing and Development 45:223 (1988).PubMedCrossRefGoogle Scholar
  55. Richie, J.P., McDonald, J., and Gittes, R.F. Resistance to intravenous tumor metastases in the athymic nude mouse: a paradoxic response. Surgery 90:214 (1981).PubMedGoogle Scholar
  56. Rockwell, S.C., Kallman, R.F., and Fajardo, F. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture adapted derivative. J. Nat. Cancer Inst. 49:735 (1972).PubMedGoogle Scholar
  57. Rockwell, S.C. Effect of host age on transplantation, growth and radiation response of EMT6 tumors. Cancer Research 41:527(1981).PubMedGoogle Scholar
  58. Sandru, G., Verguth, P., and Stadler, B.M. Stimulation of tumor growth in humans by a mononuclear cell-derived factor. Cancer Research 48:5411 (1988).PubMedGoogle Scholar
  59. Schottenfeld, D. and Robbins, G.F. Breast cancer in elderly women. Geriatrics 71:121 (1971).Google Scholar
  60. Serge, M. and Serge, D. Humoral immunity in aged mice. I. Age-related decline in the secondary responses to DNP of spleen cells propagated in diffusion chambers. J. Immunol. 116:731(1976).Google Scholar
  61. Sidky, Y. and Auerbach, R.A. Lymphocyte-induced angiogenesis in tumor bearing mice. Science 192:1237 (1976).PubMedCrossRefGoogle Scholar
  62. Sjogren, H.O., Hellstrom, I., Bansal, S.C., and Hellstrom, K.E. Suggestive evidence that the blocking antibodies of tumor bearing individuals may be antigen-antibody complexes. Proc. Nat. Acad. Sci.(USA), 68:1372 (1971).CrossRefGoogle Scholar
  63. Stjernsward, J. Age-dependent tumor host barrier and effect of carcinogen induced immunodepression on rejection of isografted methylcholanthrene-induced sarcoma cells. J. Nat. Cancer Inst. 37:505 (1966).PubMedGoogle Scholar
  64. Stutman, O. Cell-mediated immunity and aging. Fed. Proc. 33:2028 (1974).PubMedGoogle Scholar
  65. Suen, K.C., Lau, L.L. and Yermakov, V. Cancer and old age. An autopsy study of 3535 patients over 65 years old. Cancer 33:1164 (1970).CrossRefGoogle Scholar
  66. Suzuki, T., Koga, N., Imamura, T., and Mitsui, Y. A novel growth factor in rat spleen which promotes proliferation of hepatocytes in primary culture. Biochem. and Biophys. Research Com. 153:1123 (1988).CrossRefGoogle Scholar
  67. Tamerius, J., Nepom, J., Hellstrom, I. and Hellstrom, K.E. Tumor associated blocking factors; isolation from sera of tumor-bearing mice. J. Immunol. 116:724 (1976).PubMedGoogle Scholar
  68. Thoman, M. and Weigle, W.O. Cell mediated immunity in aged mice: An underlying lesion in IL-2 synthesis. J. Immunol. 128:2358 (1982).PubMedGoogle Scholar
  69. Thoman, M. and Weigle, W.O. Lymphokines and aging: Interleukin-2 production and activity in aged animals. J. Immunol. 127:2102 (1981).PubMedGoogle Scholar
  70. Thoman, M.L. and Weigle, W.O. The cellular and subcellular bases of Immunosenescence., Advances in Immunology 46:221 (1989).PubMedCrossRefGoogle Scholar
  71. Treves, A.J., Carnaud, C., Trainin, N., Feldman, M., and Cohen, I.R. Enhancing T-lymphocytes from tumor bearing mice suppress host resistance to a syngeneic tumor. Eur. J. Immunol. 4:722 (1974).PubMedCrossRefGoogle Scholar
  72. Treves, A.J., Cohen, I.R., and Feldman, M. Suppressor factor secreted by T lymphocytes from tumor bearing mice. J. Natl. Cancer Inst. 57:409 (1976).PubMedGoogle Scholar
  73. Tsuda, T., Kim, Y.T., Siskind, G.W., DeBlasio, A., Schwab, R., Ershler, W.B. and Weksler, M.E. Role of the thymus and T-Cells in slow growth of B16 melanoma in old mice. Cancer Research 47:3097(1987).PubMedGoogle Scholar
  74. Urban, J.L., Burton, R.C., Holland, J.M., Kripkem M.L. and Schreiber H. Mechanisms of syngeneic tumor rejection: susceptibility of host selected progressor variants to various immunologic effector cells. J. Exp. Med. 155:557 (1982).PubMedCrossRefGoogle Scholar
  75. Urban, J.L. and Schreiber, H. Rescue of the tumor-specific immune response of aged mice in vitro. J. Immunol. 133:527 (1984).PubMedGoogle Scholar
  76. Weksler, M.E., Innes, J.B., and Goldstein, G. Immunological studies of aging IV. The contribution of thymic involution to the immune deficiencies of aging mice, and reversal with thymopoietin. J. Exp. Med. 148:996 (1976).CrossRefGoogle Scholar
  77. Wu, W., Pahlavani, M., Cheung, H.T. and Richardson, A. The effect of aging on the expression of Interleukin-2 messenger ribonucleic acid. Cellular Immunology. 100:224 (1986).PubMedCrossRefGoogle Scholar
  78. Yuhas, J.M., Pazmino, N.H., Proctor, J.O., and Toya, R.E. A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor. Cancer Research 34:722 (1974).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • William B. Ershler
    • 1
  1. 1.Department of MedicineUniversity of WisconsinMadisonUSA

Personalised recommendations